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ABSTRACT: N-Terminal acetylation of α-synuclein (aS), a
protein implicated in the etiology of Parkinson’s disease, is
common in mammals. The impact of this modiﬁcation on the
protein’s structure and dynamics in free solution and on its
membrane binding properties has been evaluated by high-
resolution nuclear magnetic resonance and circular dichroism
(CD) spectroscopy. While no tetrameric form of acetylated aS
could be isolated, N-terminal acetylation resulted in chemical
shift perturbations of the ﬁrst 12 residues of the protein that
progressively decreased with the distance from the N-terminus.
The directions of the chemical shift changes and small changes in backbone 3JHH couplings are consistent with an increase in the
α-helicity of the ﬁrst six residues of aS, although a high degree of dynamic conformational disorder remains and the helical
structure is sampled <20% of the time. Chemical shift and 3JHH data for the intact protein are virtually indistinguishable from
those recorded for the corresponding N-terminally acetylated and nonacetylated 15-residue synthetic peptides. An increase in α-
helicity at the N-terminus of aS is supported by CD data on the acetylated peptide and by weak medium-range nuclear
Overhauser eﬀect contacts indicative of α-helical character. The remainder of the protein has chemical shift values that are very
close to random coil values and indistinguishable between the two forms of the protein. No signiﬁcant diﬀerences in the
ﬁbrillation kinetics were observed between acetylated and nonacetylated aS. However, the lipid binding properties of aS are
strongly impacted by acetylation and exhibit distinct behavior for the ﬁrst 12 residues, indicative of an initiation role for the N-
terminal residues in an “initiation−elongation” process of binding to the membrane.
T
he link between mutations in the gene encoding α-
synuclein (aS) and familial early onset Parkinson’s
disease
1,2 has stimulated a very wide array of biophysical
studies of this protein.
3,4 In aqueous solution, this 140-residue
protein adopts a dynamically disordered backbone conforma-
tion, but its 13Cα chemical shifts also have been interpreted as
being indicative of a slight propensity to adopt α-helical torsion
angles for several sections of its backbone.
5,6 Electrostatic
interaction between the, on average, 100 positively charged N-
terminal residues and the negatively charged C-terminal tail
results in a hydrodynamic radius (Rh =2 8Å )
7 that is smaller
than expected for a true random coil (∼37 Å) but larger than
the value of ≈15 Å for a globular protein with the mass of aS.
A recent study suggests that when expressed in mammalian
cells, aS can also form a stable helical tetramer,
8 and the same
conclusion was reached for a form of aS that included an N-
terminal decapeptide extension, remaining after cleavage of its
GST tag.
9 In both cases, aS was puriﬁed without the heating
step, usually employed in aS puriﬁcation as an eﬀective way to
precipitate the vast majority of other, folded proteins. However,
the conclusions of both studies remain the subject of much
debate.
10
The N-terminal 100-residue segment of aS has a high aﬃnity
for negatively charged lipids
11,12 and adopts an α-helical
conformation when bound to the surface of small unilamellar
vesicles (SUVs) or detergent micelles.
13−17 However, virtually
all biophysical studies of aS conducted to date have focused on
bacterially overexpressed protein, which lacks post-translational
acetylation of the N-terminal residue, a modiﬁcation commonly
found in mammalian proteins.
18 Indeed, extensive N-terminal
acetylation of aS was detected when it was isolated from
erythrocytes.
8 Considering the critical role of the N-terminal aS
residues in its interaction with phospholipids,
17,19,20 it therefore
is of interest to evaluate the impact of N-terminal acetylation. A
very recent study reports that N-terminal acetylation is
responsible for the formation of folded, α-helical aS tetramers.
21
Selective chemical acetylation of bacterially expressed aS is
challenging because of the many Lys amino groups in the
protein. However, a recently developed recombinant expression
system
22 includes a plasmid for overexpression of the requisite
acetylation enzyme NatB and permits bacterial expression of N-
terminally acetylated and isotopically enriched aS, needed for
NMR studies. Using the recently described “soft” puriﬁcation
protocol,
21 we were unable to generate aS samples of suﬃcient
purity for detailed biophysical studies. In an unsuccessful
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aS construct extended with a C-terminal His tag, allowing for
eﬀective protein puriﬁcation by using a nickel aﬃnity column,
thereby eliminating the heat denaturation step.
Here, we report primarily on the impact of N-terminal
acetylation on the structural and lipid binding properties of
wild-type aS (lacking the His tag), as viewed by NMR and CD
spectroscopy. We evaluate the eﬀect of the acetylation both on
chemical shifts, which are extremely sensitive to even minute
structural diﬀerences, and on 3JHN−Hα couplings that are
accurate residue-speciﬁc reporters of the distribution of the
backbone torsion angle ϕ. Our results show that in the absence
of lipids the eﬀect of acetylation is completely restricted to the
12 N-terminal residues. We therefore also evaluate the impact
of acetylation on a 15-residue N-terminal peptide fragment of
aS by both CD and NMR spectroscopy. Although the structural
impact of acetylation remains strictly limited to transient
formation of a very short α-helical segment at the very N-
terminus of the protein, we ﬁnd a strong increase in lipid
binding aﬃnity for acetylated aS.
■ MATERIALS AND METHODS
Protein Expression and Puriﬁcation. Expression and
puriﬁcation of nonacetylated wild-type (WT) aS were
conducted largely as described previously.
17 Brieﬂy, bacteria
were grown in M9 medium at 37 °Ct oa nO D 600 of 0.6, and
the protein production was induced by addition of 1 mM
IPTG. Cells were harvested by centrifugation 3 h later and
immediately frozen at −80 °C. Lysis of cells and initial protein
puriﬁcation were achieved by several freeze−thaw cycles
followed by heat precipitation (15 min at 85 °C) in 50 mM
Tris (pH 7.4) and 500 mM NaCl. Streptomycin was added at a
concentration of 10 mg/mL to partially precipitate DNA. The
solution was then centrifuged at 50000g for 30 min, and the
supernatant was diluted 10-fold with 50 mM Tris buﬀer (pH
7.4). Anion-exchange chromatography on a Q-Sepharose
column was performed, and fractions containing aS were
pooled together. As the ﬁnal puriﬁcation step, which principally
served to remove residual DNA, size-exclusion chromatography
was performed on a Superdex 75 HiLoad 16/60 prep grade
column in 20 mM Tris (pH 7.4) and 50 mM NaCl. The
protein was then dialyzed into water and lyophilized for
storage.
Expression of Acetylated Protein. N-Terminal acetyla-
tion of WT aS was achieved by coexpression of a plasmid
carrying the components of the NatB complex with a plasmid
containing the wild-type aS gene, following the protocol
described by Johnson et al.
22 We observed that the restrictive
conditions of M9 media have a strong eﬀect on the acetylation
reaction. Essentially complete acetylation (≥98%) was observed
only when using protonated M9 medium, supplemented with 1
g/L protonated IsoGro (Sigma, St. Louis, MO). IsoGro is a
protein hydrolysate and to some extent mimics LB medium. In
protonated M9 supplemented with MEM vitamins, but lacking
IsoGro, the extent of acetylation was only ∼85%. In fully
deuterated M9, including 99% D2O solvent, supplemented with
1 g/L [2H,15N]IsoGro, the extent of acetylation was only
∼40%. Notably, upon expression of aS in fully deuterated M9
supplemented with MEM vitamins but in the total absence of
IsoGro, no signiﬁcant acetylation could be detected. Unless
noted otherwise, all NMR experiments with acetylated aS were
performed on 15N- and 13C-labeled aS samples, obtained using
[15N,13C]IsoGro.
Expression and Puriﬁcation of Acetylated His-Tagged
aS. For the purposes of eﬃcient puriﬁcation while avoiding a
heat denaturation step, we used a C-terminally His-tagged aS
construct. The sequence of the protein matched the full
sequence of wild-type aS, followed by one Gly and six His
residues. The gene was synthesized and placed into the pGS21a
plasmid, carrying ampicillin resistance, by GenScript.
Escherichia coli carrying aS-His and NatB plasmids were
cultured in 1 L of fully protonated M9 medium supplemented
with [15N]IsoGro. Protein production was induced at an OD600
of 0.6 via addition of 1 mM IPTG. Bacteria were collected by
centrifugation 3 h after induction. The cell pellet was
immediately resuspended in 20 mL of BOG buﬀer matching
that described by Trexler and Rhoades
21 [100 mM HEPES, 20
mM NaCl, 10% glycerol, and 0.1% BOG (pH 7.4)] with the
addition of one full Complete protease inhibitor tablet
(Roche). The cell suspension was lysed using a pressure cell,
and the lysate then was cleared by centrifugation at 50000g for
30 min. The supernatant was loaded on a 5 mL Ni column. The
column was washed with BOG buﬀer, including 20 mM
imidazole. Target protein was then eluted with BOG buﬀer and
250 mM imidazole, yielding 10 mL of eluate. This solution was
dialyzed overnight at 4 °C into a buﬀer better suited for NMR
measurements [1× PBS, 5% glycerol, and 0.05% BOG (pH
7.4)]. On the basis of the UV absorption measurement, the
ﬁnal protein concentration was 150 μM and the total protein
yield was 22 mg. NMR measurements were performed on the
dialyzed protein after the addition of 7% D2O and a decrease in
the pH to 6 by titration with a 0.1 M HCl stock solution. The
time between lowering the pH and the start of the NMR
experiments was ∼15 min.
Preparation of SUVs. Phospholipids were purchased from
Avanti Polar Lipids (Alabaster, AL) as lyophilized powders of
pure DOPC and a DOPE/DOPS/DOPC mixture with a 5:3:2
weight ratio (coagulation reagent I). A lipid mixture that
consisted of approximately 15% DOPS, 25% DOPE, and 60%
DOPC was also prepared by codissolving equal amounts of
coagulation reagent I and DOPC in chloroform followed by
solvent evaporation under a stream of N2 gas. SUVs were
prepared as described previously
17 in 20 mM sodium
phosphate buﬀer [pH 6, 10% (w/v)].
NMR Spectroscopy. Diﬀusion measurements were per-
formed on a 600 MHz Bruker spectrometer equipped with a
triple-gradient room-temperature probe using the water-sLED
experiment
23 with observation optimized for the methyl region
of the spectrum. The samples contained 100 μM protein and 5
mM dioxane (internal reference) in 20 mM sodium phosphate
buﬀer (pH 6). Experiments were performed at 288 K using a
diﬀusion delay of 300 ms and 1 ms x,y-gradient pulses with
intensities set to 2, 8, 10, 12, 20, 25, 30, 35, 40, 44, 46, and 48%
of the maximal value. An acquisition time of 200 ms was used,
and 2048 scans with a 1.6 s interscan delay were collected for
each gradient strength. Peak attenuations were measured in the
methyl region of the spectrum, by scaling relative to the
spectrum collected for the weakest gradient, using the dual-
mode feature of Bruker XwinNMR, and hydrodynamic radii
were extracted using the dioxane hydrodynamic radius (2.12 Å)
as an internal reference.
For the backbone chemical shift assignments, three-dimen-
sional (3D) TROSY-HNCO and TROSY-HNCACB spectra
were recorded on 15N- and 13C-labeled WT aS (0.35 mM
nonacetylated aS and 0.45 mM N-terminally acetylated aS) at
288 K, using a 600 MHz Bruker Avance II spectrometer
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cryogenic probe. All data were collected with two scans per free
induction decay. The HNCO spectra comprised 70*×200*×
575* complex points, for acquisition times of 70.7, 150, and
76.7 ms in the 13C, 15N, and directly detected 1H dimensions,
respectively. An acquisition time in the 15N dimension much
longer than the 1JNC′ refocusing INEPT delay, typically around
30 ms, was achieved by using the mixed-time (MT) evolution
approach
24 without requiring additional pulses. With an
interscan delay of 0.8 s, the total measuring time for each
HNCO spectrum was approximately 1.5 days.
The TROSY-HNCACB spectra were collected using the
acquisition parameters listed above in the 15Na n d1H
dimensions. The 13C chemical shift was recorded using a 28
ms constant-time evolution (212 complex pairs of data points)
to remove the 1JCC coupling and achieve an increased
resolution. All the TROSY-HNCACB data were collected
using 15% sparse sampling, with the sampling schedule in the
two indirect dimensions generated randomly. The ﬁnal spectra
were reconstructed on a Linux computer containing dual six-
core Xeon processors using 400 iterations of the recently
described IST method
25 at a threshold value of 0.98. The
interscan delay was set to 1.4 s, and the total measuring time for
each experiment was approximately 24 h. Standard data
processing and most analyses were conducted using
NMRPipe.
26 Backbone assignments were traced using
SPARKY.
27
The 3JHN−Hα couplings were measured at 288 K from the
cross-peak intensity modulation in a series of constant-time
1H−15N HMQC spectra,
28 recorded at 900 MHz. In total, nine
constant-time delays with durations of 50, 60, 75, 95, 140, 180,
210, 240, and 280 ms were used, which samples a J modulation
curve with up to two zero crossing points for the majority of
residues. Depending on the length of the JHH modulation time,
the data matrix size ranges from 79*×1024* in the 15N and
1H dimensions for the shortest constant-time duration to 579*
× 1024* points for the longest constant-time duration, with a
103.2 ms 1H acquisition time in all the experiments. Cross-
peaks were picked from the spectrum with the longest 15N
acquisition time and therefore the highest resolution, unless it
was near the zero crossing point and the peaks were too weak
for a reliable determination of the peak positions, in which case
the next best resolved spectrum was used. With the peak
positions accurately determined, the autoFit.tcl routine in the
NMRPipe software package
26 was applied to extract the peak
intensity in each spectrum, keeping the position ﬁxed.
Nonlinear least-squares ﬁtting of the J-modulated peak
intensities to eq 4 of ref 28 was performed to obtain the 3JHH
couplings.
Two-dimensional (2D) TOCSY and NOESY spectra were
recorded at 278 K on peptide samples containing 1.6 mM
nonacetylated and 1.0 mM acetylated N-terminal 15-residue
peptides, both amidated at V15, using a 900 MHz Bruker
Avance III spectrometer with a cryogenic probe. For the
NOESY spectra, a mixing time of 300 ms was used. In all the
spectra, 512*×2048* complex points in the indirect and direct
dimensions were collected for acquisition times of 69.6 and 227
ms. The interscan delay was set to 1.5 s, with four and eight
scans per free induction decay, yielding total measuring times of
2 and 4.5 h for the 2D TOCSY and NOESY spectra,
respectively.
TROSY-HSQC spectra were recorded at 1H frequencies of
500 and 800 MHz on Bruker spectrometers equipped with
cryogenic probes. At 500 MHz, 200*×560* complex points
were collected for acquisition times of 165 (t1) and 80 ms (t2).
At 800 MHz, 300*×900* complex points were collected for
acquisition times of 154 (t1) and 80 ms (t2).
CD Measurements. All CD measurements were taken at
20 °C, using a 1 mm path-length cuvette. Samples contained 20
mM sodium phosphate (pH 6), 150 mM NaCl buﬀer, and
either 100 μM 15-residue peptides or 10 μM full-length
protein.
Fibrillation Experiments. Experiments were performed
using a Tecan Inﬁnite 200 Pro multimode microplate reader.
The sample volume was 200 μL per well. Sample conditions
were as follows: 200 μM WT aS, either acetylated or
nonacetylated, PBS buﬀer, pH 7.4. The plate was shaken at
88 rpm and 37 °C. A 1 mm diameter glass bead was placed into
each sample well to accelerate ﬁbrillation. Fibril formation was
followed using the ﬂuorescence of thioﬂavin T (ThT), which
was added at a concentration of 10 μM to all samples. The
instrument took ﬂuorescence readings of all samples at regular
intervals of 50 min for a total duration of 92 h. The excitation
wavelength was set to 415 nm, and the ThT emission was
measured at 480 nm. Four samples for acetylated and three for
nonacetylated aS were measured.
■ RESULTS AND DISCUSSION
The recently introduced bacterial expression system coex-
presses the ﬁssion yeast NatB enzyme complex together with
the protein of interest. It provides an eﬀective method for
obtaining N-terminal acetylation of proteins such as aS, which
starts with a Met-Asp pair at its N-terminus.
22 Using the regular
bacterial strain BL21(DE3), we obtained yields of acetylated
WT aS that were comparable to amounts normally harvested
for nonacetylated protein (∼20 mg/L) when expressed in
minimal media, required for incorporation of 13C and 15N
stable isotopes. With no resonances visible in the 15N−1H
HSQC NMR spectrum at the positions of the nonacetylated
protein, levels of acetylation were established to be >98%.
However, when an attempt was made to express perdeuterated
aS, which can generate extremely well resolved 15N−1H
correlation spectra for aS,
29 the level of acetylation was at
most 40% (for more details, see Materials and Methods). All
results presented in this study therefore are for fully protonated
material.
Eﬀect of Acetylation on NMR Characteristics of aS. A
comparison of the 15N−1H HSQC NMR spectra of N-
terminally acetylated and nonacetylated WT aS reveals the
impact of acetylation to be strictly limited to the ﬁrst 12
residues of the protein, and both line widths and resonance
positions are essentially indistinguishable for the remainder of
the protein, despite the very high precision at which these
values were recorded (Figure 1). Backbone assignments
(Tables S1 and S2 of the Supporting Information) were
obtained from nonuniformly sampled HNCACB 3D spectra.
Evaluation of the actual chemical shift values in terms of
secondary structure propensity, using the latest sets of
sequence, pH, and temperature correction factors,
30 shows
root-mean-square diﬀerences (rmsds) from random coil values
that are even considerably smaller (Figure S2 of the Supporting
Information) than previously reported for both aS and other
intrinsically unstructured proteins.
31 The newer chemical shift
evaluation method of Camilloni et al.
31 identiﬁes secondary
structure by using all available backbone chemical shifts as input
parameters. With this program, δ2D, the population of α-helix
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than initially deduced
5 from older, less advanced approaches
(Figure 2). This result is consistent with the random coil
characteristics of its CD spectrum recorded in the absence of
lipids (Figure 3A). However, δ2D indicates a small but distinct
increase in the population of α-helix near the N-terminus for
the acetylated form of the protein (Figure 2). Although the
eﬀect of N-terminal acetylation on the chemical shifts of
residues 6−12 rapidly decreases with the distance from the N-
terminus (Figure 1), it is rather remarkable that the eﬀect of
this small covalent modiﬁcation in a disordered protein
propagates as far as residue 12, an eﬀect explained by the
cooperative formation of a transient short α-helix of the N-
terminal residues.
Remarkably, there is no discernible impact of the acetylation
on the chemical shifts of the acidic C-terminal tail of the
protein, despite the decrease in positive charge and increase in
helical population at the N-terminus. An interaction between
the net positively charged N-terminus and the acidic C-terminal
region of the protein was previously established on the basis of
paramagnetic relaxation experiments and was postulated to be
primarily electrostatic in nature. The presence of such a long-
range interaction is also reﬂected in a hydrodynamic volume
Figure 1. Impact of N-terminal acetylation on the NMR spectrum of
aS. (A) Overlay of a small expanded region of the 800 MHz HSQC
spectra of nonacetylated (black) and acetylated (red) aS. The
pronounced change in the peak position for Ser9 is marked with an
arrow. For the overlay of full spectra, see Figure S1 of the Supporting
Information. Diﬀerences in chemical shifts in parts per million
between acetylated and nonacetylated aS for diﬀerent backbone atoms
as a function of residue number: (B) 13Cα, (C) 13Cβ, (D) 13C′, (E)
15N, and (F) 1HN. Pairwise rmsds calculated over residues 13−140 are
0.008 ppm (13Cα), 0.007 ppm (13Cβ), 0.005 ppm (13C′), 0.019 ppm
(15N), and 0.002 ppm (1HN).
Figure 2. Population of α-helix for nonacetylated (black) and
acetylated (red) WT aS as derived from the measured 13Cα, 13Cβ,
13C′, 15N, and 1HN chemical shifts using δ2D.
31
Figure 3. CD data for the interaction of nonacetylated (black) and
acetylated (red) WT aS with lipid vesicles. (A) Solid lines represent
CD spectra obtained at a 75:1 lipid:protein molar ratio. Dashed lines
show CD spectra in the absence of lipids. (B) Graph showing the
change in CD signature at 222 nm, reﬂecting the amount of α-helical
structure, as a function of lipid:protein molar ratio. Buﬀer conditions
were 20 mM phosphate (pH 6) and 150 mM NaCl. Measurements
were performed on samples containing 10 μM protein. The lipid
consisted of 30% DOPS, 50% DOPE, and 20% DOPC.
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of 140 residues.
7,32 The absence of any detectable chemical
shift perturbation for residues 13−140 upon losing the positive
N-terminal charge indicates that the acetylation has no
discernible eﬀect on the time-averaged backbone angles of
these residues, highlighting the absence of speciﬁc interactions
between the C-terminal region and the N-terminus. However,
very weak, nonspeciﬁc interactions between the N-terminal and
C-terminal regions are reﬂected in a slight decrease in the
global electrostatic compaction of the protein, as indicated by a
small ∼1.5% decrease in the rate of translational diﬀusion upon
acetylation of WT aS (Figure 4). The 1.5% decrease in
translational diﬀusion corresponds to a 1.5% (0.5 Å) increase in
the hydrodynamic radius and requires only extremely small
(≪1°) changes in the time-averaged backbone torsion angle
distributions. Therefore, the absence of any signiﬁcant
diﬀerence in backbone torsion angles between the acetylated
and nonacetylated forms of the protein, deduced from the
indistinguishable chemical shifts, is not inconsistent with the
slight diﬀerence in the hydrodynamic radii of the two forms of
the protein.
Next to chemical shifts, 3JHN−Hα couplings are particularly
reliable quantitative reporters of the time-averaged distribution
of the backbone torsion angles, ϕ.
33 For folded proteins with
known structures, the quantitative relation between these
torsion angles and 3JHN−Hα couplings is deﬁned by the empirical
Karplus equation. Recent work has demonstrated that this
equation is remarkably robust and typically is limited by the
accuracy of the atomic coordinates that deﬁne the ϕ angles and
by small out-of-peptide-plane deviations of the amide
protons.
34 When atomic coordinates were used that had been
reﬁned by the use of residual dipolar couplings, the level of
agreement between 3JHN−Hα couplings and backbone torsion
angles decreased to within the 0.35 Hz uncertainty of the
measurement, indicating that no correction for amino acid type
(excluding Gly) or H-bonding is needed.
34 We therefore
measured a nearly complete set of 3JHN−Hα couplings in both
acetylated and nonacetylated aS. With the exception of small
decreases in 3JHN−Hα for the ﬁrst few residues in the protein
upon acetylation (Table S4 of the Supporting Information), the
values measured for the two forms of the protein are essentially
indistinguishable (rmsd of 0.05 Hz).
It is interesting to note, however, that the diﬀerent residue
types show distinct clustering of their 3JHN−Hα values (Table S4
of the Supporting Information), with the smallest values found
for Ala residues (⟨3JHN−Hα⟩ = 5.64 ± 0.26 Hz, excluding C-
terminal A140) and the largest values found for β-branched
residues such as Val (⟨3JHN−Hα⟩ = 7.60 ± 0.29 Hz), reﬂecting
the natural tendencies of these amino acids to populate more
helical or extended regions of Ramachandran space in
intrinsically unstructured peptides and proteins. The ﬁrst six
residues of acetylated aS show decreases relative to these
random coil values that fall outside the standard deviation,
again indicative of α-helix. Residues following G7 do not show
such an eﬀect.
Eﬀect of Acetylation on an N-Terminal 15-Residue
Peptide Fragment. As the impact of acetylation appears to be
restricted to the ﬁrst few residues of aS, we also studied the
synthetic 15-residue N-terminal fragment of the protein in the
absence and presence of N-terminal acetylation. Because of
their much smaller number of residues, these peptides exhibit
far less 1H resonance overlap than the full-length protein and
make it possible to study their structure by the conventional 2D
NOESY method. With the exception of residues 13−15,
proximate to the C-terminus of the peptide, the chemical shifts
of the two peptides match those seen in the corresponding full-
length proteins very closely, lending validity to the study of
these peptides. The nonacetylated peptide shows essentially
random coil characteristics. Its 2D NOESY spectrum lacks
medium-range (i, i + n;2≤ n ≤ 5) NOEs at the lowest contour
level. By contrast, weak dαβ(i,i+3), dαN(i,i+3), and dαN(i,i+4)
NOEs point to α-helical character for the ﬁrst six residues of
the acetylated peptide (Figure S3 of the Supporting
Information). However, upon quantitative comparison of the
intraresidue dαN(i,i) and sequential dαN(i−1,i) NOE intensities,
these ratios remain considerably below unity. As pointed out
previously,
35,36 the dαN(i,i)/dαN(i−1,i) NOE intensity ratio is
very sensitive to the value of the ψ angle of residue i − 1 and
ranges from ∼6 for α-helix to ∼0.25 for β-sheet. Ratios
observed in the absence of acetylation are very close to values
of ∼0.35, typical of fully disordered proteins. A decrease of
∼50% in the intensity of the sequential dαN(i−1,i) NOEs for
residues V3 and F4 increases the NOE intensity ratio to >0.5
(Figure 5), consistent with a shift to an increased population of
helical backbone angles compared to random coil. However,
Figure 4. Linearized (logarithmic) PFG diﬀusion plots for non-
acetylated (black) and acetylated (red) WT aS. Proton peak intensities
were observed in the methyl region. Dashed lines represent linear ﬁts
to the symbols of the matching color.
Figure 5. Ratios of intraresidue to sequential Hα−HN NOE intensities,
dαN(i,i)/dαN(i−1,i), for the ﬁrst 10 residues of the nonacetylated
(black) and acetylated (red) 15-residue N-terminal peptides. The ratio
for residue G7 was divided by 2, and the ratio for L8 was multiplied by
2 to roughly account for the presence of two Hα protons on G7. Ratios
for the full-length, nonacetylated protein can be found in ref 36.
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clearly indicates that the population of α-helical conformations
remains low, fully consistent with the analysis of chemical shifts,
described above.
Only a very slight increase in α-helicity is observed in the CD
spectrum of the full aS protein upon acetylation (Figure 3A),
because the CD signal remains dominated by the random coil
character of the ∼95% of the chain that is not impacted by the
N-terminal acetylation. However, upon comparison of the CD
spectra of the N-terminal 15-residue peptides, an increase in α-
helical character is clearly observed upon acetylation (Figure S4
of the Supporting Information). Consistent with the NMR
results, the degree of α-helicity remains low, however.
Estimated Increase in the Helicity of the First Five
Residues. N-Terminal acetylation is known to stabilize α-
helices.
37,38 For the ﬁrst few residues of N-terminally acetylated
aS in the absence of lipids and detergents, comparison of
3JHN−Hα couplings as well as 13Cα and 13Cβ chemical shifts with
those of the nonacetylated protein shows a small increase in the
propensity for α-helical structure. Acetylation results in an ∼0.5
ppm increase in the 13Cα chemical shifts for the ﬁrst ﬁve
residues and progressively smaller increases for the following
few residues. Assuming an ∼3 ppm secondary chemical shift for
an ideal α-helix, this indicates an ∼17% increase in the α-helical
population for the ﬁrst ﬁve residues.
Upon acetylation, 3JHN−Hα decreases by ∼0.5 Hz for residues
3−5, whereas the value for K6 (6.1 Hz) falls about two
standard deviations or 0.5 Hz below the values observed for Lys
residues in the remainder of the chain for both forms of the
protein (Table S4 of the Supporting Information). With an
average 3JHN−Hα of 4 Hz expected for an ideal α-helix and a
3JHN−Hα of ≈7 Hz for random coil, the approximate increase in
the level of α-helical conformation is also estimated to be
∼17%.
CD measurements show a markedly stronger helical
signature for the acetylated N-terminal 15-residue peptide
than for the nonacetylated peptide (Figure S4 of the
Supporting Information). If this increase is attributed solely
to a change in helical content, then the average increase in
helicity is ∼6% (according to JFit). Considering that on the
basis of our NMR chemical shift perturbation this change can
be attributed to the ﬁrst ﬁve residues, the 6% increase in
average helicity corresponds to an ∼18% increase in helicity for
these ﬁve residues.
Thus, the three independent indicators of helical propensity
all indicate an increase in helicity for the ﬁrst ﬁve residues of
∼17%, a number that is slightly larger than the smoothed 11%
increase reported by the δ2D program of Camilloni et al.,
31
which takes into account all backbone secondary chemical
shifts.
Impact of Acetylation on Lipid Binding. Interactions
between aS and a variety of diﬀerent types of lipid vesicles have
previously been studied by optical spectroscopic methods, in
particular CD,
11,13 as well as by both continuous wave and
pulsed EPR
14,15,39−42 and solution NMR
5,29 spectroscopies. All
of these techniques indicate a transition from a disordered to an
α-helical state upon lipid binding, with some debate remaining
about whether the ﬁrst ∼100 residues form a single contiguous
helix or whether aS adopts a ﬂexibly tethered two-helix
structure, as was seen in the presence of small SDS
micelles.
16,43 The various studies unanimously agreed on the
important role of negative membrane charge in the interaction,
with the highest aﬃnity for lipids with phosphatidylglycerol and
phosphatidylserine headgroups and a very low aﬃnity for
neutral, zwitterionic phosphatidylcholine lipids, an observation
solidiﬁed by ﬂuorescence correlation spectroscopy.
12
Even when using very dilute suspensions of negatively
charged small unilamellar vesicles (SUVs), corresponding to a
lipid:protein molar ratio as low as unity, signiﬁcant attenuation
of NMR resonance intensity of the N-terminal residues of aS
was observed.
17 Remarkably, the attenuated N-terminal HSQC
cross-peaks are not shifted relative to those seen in lipid-free
samples and show an only very small degree of line broadening,
indicating a slow exchange process between the free, disordered
state and the lipid-bound state. The absence of attenuation seen
for the C-terminal residues indicates that these residues retain
their dynamically disordered, random coil character even when
the corresponding N-terminal amides have converted to an
NMR-invisible “dark state”, induced by lipid binding.
17,29
Here, we evaluated the impact of N-terminal acetylation of
aS on lipid binding by both CD and NMR spectroscopy. CD
measurements were taken under conditions of 20 mM sodium
phosphate buﬀer (pH 6) and 150 mM NaCl at 20 °C, using
SUVs composed of 30% DOPS, 50% DOPE, and 20% DOPC.
This commercially available lipid mixture is convenient for
generating highly stable and reproducible SUVs and includes
the headgroups of some of the most abundant phospholipids
found in synaptic vesicles.
44 At an intermediate lipid:protein
molar ratio of 75, the CD spectra show a substantially higher α-
helical content for acetylated aS (Figure 3A). A full titration
curve, probing the eﬀect of lipid binding on helicity over a wide
range of lipid:protein stoichiometries, indicates that acetylated
aS has a roughly 2-fold higher aﬃnity for the negatively charged
lipid vesicles than does nonacetylated protein (Figure 3B).
NMR experiments were performed under the same buﬀer
conditions but at 15 °C, with lipid vesicles composed of 15%
DOPS, 25% DOPE, and 60% DOPC. Vesicles with lower
charges were used because this decreases their aﬃnity for aS
and thereby weakens the eﬀect of crowding on their surface
when aS binds to them. These lower-aﬃnity vesicles are less
suitable for CD measurements because of interference from
SUV scattering at high lipid concentrations but are well suited
for NMR measurements. As one can see in Figure 6, the general
shape of the attenuation proﬁle observed for the nonacetylated
protein shows the same stepwise attenuation proﬁle as
Figure 6. Ratios of WT aS TROSY-HSQC peak heights in the
presence (I) and absence (Io) of lipids. Data from the following three
samples are presented: acetylated aS at a lipid:protein (L:P) ratio of 22
(red circles), nonacetylated aS at an L:P ratio of 22 (black triangles),
and nonacetylated aS at an L:P ratio of 44 (black circles). Experiments
were performed on 200 μM protein samples in 20 mM phosphate (pH
6) and 150 mM NaCl buﬀer at 15 °C on an 800 MHz spectrometer.
The lipid consisted of 15% DOPS, 25% DOPE, and 60% DOPC.
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higher charge density.
17 Remarkably, however, the acetylated aS
shows a distinct additional attenuation for the ﬁrst 12 residues,
followed by the transition to the characteristic ﬂat proﬁle for
residues 25−90 (Figure 6). The same average attenuation of
residues 25−90 is achieved for acetylated aS at 2-fold lower
lipid concentration, compared to that of the nonacetylated
protein. This observation is consistent with the ∼2-fold higher
lipid aﬃnity of acetylated aS, indicated by the CD measure-
ments.
Eﬀect of Acetylation on aS Fibrillation. The impact of
N-terminal acetylation on the ﬁbril forming propensity of aS, in
the absence of lipids, was investigated by measurement of the
ﬁbrillation kinetics of the two forms of the protein, using a
Tecan Inﬁnite 200 Pro multimode microplate reader to
monitor ThT ﬂuorescence. Readings were taken automatically
every 50 min for 92 h under conditions of continuous agitation
at 37 °C, using four and three separate samples for the
acetylated and nonacetylated aS, respectively. The amount of
data available so far remained limited by the amounts of
available protein and showed some spread in both the lag time
and growth rate of the ﬁbrils (Figure S5 of the Supporting
Information). However, these data point to the absence of any
signiﬁcant impact of N-terminal acetylation on either the lag
phase or the ﬁbril elongation rate. Indeed, under our
conditions, both acetylated and nonacetylated aS showed an
∼20 h lag phase and an ∼22 h ﬁbril elongation phase. The
absence of any eﬀect on ﬁbrillation could not be anticipated
considering that mutations quite close to the N-terminus of the
nonacetylated protein, such as V16P, have been reported to
inhibit aS ﬁbrillation substantially.
45 On the other hand, this
absence of any eﬀect appears to be consistent with the notion
that the structural changes induced by acetylation are very
remote from the hydrophobic NAC region of aS (residues 61−
95), the main region implicated in aS ﬁbrillation.
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■ CONCLUDING REMARKS
The vast majority of the very wide array of biophysical
measurements reported to date on the structural character-
ization of aS as well as its interaction with lipids have been
taken on bacterially expressed protein that lacks the N-terminal
acetylation, a post-translational modiﬁcation that is present to a
very high degree in mammalian cells. An initial report on
mammalian-expressed aS suggested the protein exists as an α-
helical tetramer,
8 a ﬁnding subsequently attributed to its N-
terminal acetylation
21 but disputed by a number of other
research groups.
10
All of the work described above involving full-length protein
was performed on aS that underwent a heating step during
puriﬁcation. We tried to replicate the procedure followed by
Trexler and Rhoades
21 but failed to isolate the putative
tetrameric form of the protein, possibly because of diﬃculties in
separating it from a host of other proteins. Although the
isolated material showed considerable α-helical character as
judged by CD, it was heterogeneous in mass and showed
precipitation after the sample had been heated to 90 °C,
characteristic of irreversible denaturation. To work around
these diﬃculties with aS puriﬁcation under nondenaturing
conditions, we resorted to adding a C-terminal His tag to aS.
Using this new construct, we were able to perform gentle
puriﬁcation and obtain highly pure N-terminally acetylated
protein (see Materials and Methods for details). The resulting
protein showed the same dynamic disorder that was seen for
nonacetylated or acetylated monomeric protein, despite the
absence of a heat denaturation step and very mild conditions
used during puriﬁcation. When using carefully matched buﬀer
conditions, the only diﬀerences between the NMR spectra of
the gently puriﬁed acetylated His-tagged aS and acetylated WT
aS, lacking the His tag but puriﬁed using heat denaturation, are
localized to the C-terminal residues, presumably reﬂecting the
eﬀect of a weak electrostatic interaction between the mostly
positively charged His tag (at pH 6.0) and the mostly
negatively charged C-terminal residues (Figure 7). It is
conceivable that the C-terminal His tag prevents the formation
of the putative tetramer. However, this scenario seems unlikely
because in the proposed structure of the tetramer the C-
terminal region of aS remains disordered.
9
In the absence of lipids, the N-terminal acetylation of aS
induces a modest ∼17% population of α-helical conformation
for the ﬁrst six residues. However, the exchange between α-
helix and random coil takes place on a time scale faster than ∼1
μs, as judged by the absence of signiﬁcant line broadening for
these N-terminal residues. In the absence of lipids, the chemical
shifts of only the very N-terminal residues of aS are visibly
impacted by the acetylation and no signiﬁcant perturbations
can be seen in the NMR spectrum beyond residue 12.
Considering that the NMR resonances are exquisitely sensitive
to the distribution of backbone torsion angles sampled by the
molecule, this strongly suggests the absence of any speciﬁc
interactions of other aS residues with this transient small N-
terminal helical segment. At ﬁrst sight, the very small, ∼1.5%
increase in the hydrodynamic radius of aS upon acetylation
might appear to contradict the absence of long-range
interactions. However, it appears that the 20% lower hydro-
dynamic radius of aS compared to a total random chain of the
same length simply reﬂects a small electrostatic compaction
caused by the opposite net charge between the 40 C-terminal
residues and the 60 N-terminal residues. This charge diﬀerence,
and thereby the compaction, is reduced by the removal of one
elementary positive charge upon acetylation of the N-terminal
amino group.
Figure 7. Overlay of small expanded regions of the TROSY-HSQC
spectra of N-terminally acetylated, C-terminally His-tagged aS after
soft puriﬁcation (red) and of acetylated WT aS that had undergone
heating during puriﬁcation (black), recorded under matching buﬀer
conditions [1× PBS, 5% glycerol, 0.05% BOG, and 7% D2O (pH 6)].
Spectra were acquired on a 500 MHz spectrometer equipped with a
cryoprobe. The signature position of the S9 peak indicates that both
proteins are indeed N-terminally acetylated. The only peaks that show
small chemical shift diﬀerences between the two samples are in the
acidic C-terminal region (e.g., S129) and result from the direct eﬀect
of the His tag. The full spectrum is shown in Figure S6 of the
Supporting Information.
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acetylated aS, which extends well beyond the 20 N-terminal
residues as judged by both CD and NMR (Figures 3 and 6), is
perhaps surprising. In fact, one might have expected that the
removal of the N-terminal positive charge associated with
acetylation of the amino group would slightly decrease the
aﬃnity of aS for negatively charged lipid surfaces. Instead, we
observed that the minor change in the protein’s chemical
structure upon N-terminal acetylation, and its associated
transient ∼17% α-helical character of the ﬁrst few residues in
free solution, strongly impacts the lipid binding properties of
the entire protein. This observation points to a special and
essential role for the N-terminus of the protein in initiating
membrane binding, prior to elongation of the bound section of
the protein beyond its dozen immediate N-terminal residues.
This “initiation−elongation” model of binding is consistent
with the stepwise decrease in NMR resonance attenuation seen
in the presence of small quantities of SUVs when moving
farther from the N-terminus
17 and explains the strong increase
in the level of lipid binding upon acetylation. Indeed, with the
helical structure of aS in the lipid-bound state being well
established, preformation of helical structure at the N-terminus
in aqueous solution will signiﬁcantly increase the on rate for
binding of aS to lipid, while not signiﬁcantly aﬀecting the oﬀ
rate. This kinetic change therefore results in an increase in lipid
binding aﬃnity. The distinct steps in the attenuation proﬁle as a
function of distance from the N-terminus (Figure 6) point to
signiﬁcant kinetic barriers between aS free in solution and the
cases where either just the ﬁrst dozen residues are lipid-bound
or the entire N-terminal 100-residue region of the protein
interacts with the membrane. A special role in initiating lipid
binding has already been ascribed to the N-terminal
residues.
20,47 Our current data for acetylated aS amplify this
role considerably and suggest that N-terminal acetylation of the
protein is critical for the study of its interaction with lipid
vesicles.
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